首页 > 最新文献

Brazilian journal of cardiovascular surgery最新文献

英文 中文
Treatment of Sternocutaneous Fistula Due to Cardiac Surgery Using Extracellular Matrix Patch. 细胞外基质贴片治疗心脏外科胸骨皮瘘。
IF 1.2 Pub Date : 2025-05-05 DOI: 10.21470/1678-9741-2024-0137
Zoran Tabaković, Milana Marinković, Petar Milačić, Slobodan Mićović, Igor Živković

The incidence of sternal wound complications, such as dehiscences, infections, and sternocutaneous fistulas, can reach 10%. Sternocutaneous fistulas are extremely rare, and the only definite therapy is surgical repair. Our experience taught us that combining a traditional approach with an extracellular matrix patch might be a step forward in therapy. We described three examples of surgically reconstructing sternocutaneous fistulas with an extracellular matrix patch (ProxiCor®).

胸骨伤口并发症,如裂开、感染和胸骨皮瘘的发生率可达10%。胸骨皮瘘极为罕见,唯一确定的治疗方法是手术修复。我们的经验告诉我们,将传统方法与细胞外基质贴片相结合可能是治疗的一个进步。我们描述了三个使用细胞外基质贴片(ProxiCor®)手术重建胸皮瘘的例子。
{"title":"Treatment of Sternocutaneous Fistula Due to Cardiac Surgery Using Extracellular Matrix Patch.","authors":"Zoran Tabaković, Milana Marinković, Petar Milačić, Slobodan Mićović, Igor Živković","doi":"10.21470/1678-9741-2024-0137","DOIUrl":"10.21470/1678-9741-2024-0137","url":null,"abstract":"<p><p>The incidence of sternal wound complications, such as dehiscences, infections, and sternocutaneous fistulas, can reach 10%. Sternocutaneous fistulas are extremely rare, and the only definite therapy is surgical repair. Our experience taught us that combining a traditional approach with an extracellular matrix patch might be a step forward in therapy. We described three examples of surgically reconstructing sternocutaneous fistulas with an extracellular matrix patch (ProxiCor®).</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 4","pages":"e20240137"},"PeriodicalIF":1.2,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ERRATUM. 勘误表。
Pub Date : 2025-04-23 DOI: 10.21470/1678-9741-2019-0206e
{"title":"ERRATUM.","authors":"","doi":"10.21470/1678-9741-2019-0206e","DOIUrl":"https://doi.org/10.21470/1678-9741-2019-0206e","url":null,"abstract":"","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 1","pages":"e20190206e"},"PeriodicalIF":0.0,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144057407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Five-Year Mortality of Surgical and Transcatheter Aortic Valve Replacement in the Real-World Scenario: A Systematic Review and Meta-Analysis of Propensity Score Matching Studies. 现实世界中手术和经导管主动脉瓣置换术的5年死亡率:倾向评分匹配研究的系统回顾和荟萃分析
IF 1.2 Pub Date : 2025-04-23 DOI: 10.21470/1678-9741-2024-0048
Mateo Marin-Cuartas, Bianca Dalbesio, Francesco Pollari, Matteo Scarpanti, Amedeo Anselmi, Manuela de la Cuesta, Miguel Sousa Uva, Jean-Philippe Verhoye, Francesco Musumeci, Fabio Barili, Alessandro Parolari

Introduction: Randomized controlled trials (RCTs) provide evidence of efficacy, while real-world data (RWD) demonstrate effectiveness in real-world practice. We designed a systematic review and meta-analysis of reconstructed time-to-event (RTE) data from propensity score matching studies comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) to compare their effectiveness and evaluate the generalizability of TAVI indications.

Methods: Systematic review of literature between 2007 and 2023 including propensity score matching studies comparing TAVI or SAVR that reported at least one-year Kaplan-Meier curves of endpoints.

Results: Twenty-one studies were included (39538 participants). TAVI shows a higher all-cause mortality (hazard ratio [HR] 1.41; 95% confidence interval [CI] 1.34-1.47, P-value < 0.001), with a significant heterogeneity. The analysis of HR trend over time shows that TAVI superiority is limited to the first month with a steep reversal afterwards, when SAVR becomes clearly superior. All-cause mortality is significantly higher in TAVI in low-risk (HR 1.35; 95% CI 1.08-1.69, P-value < 0.001) as well as in intermediate (HR 1.73; 95% CI 1.35-2.22, P-value < 0.001) and high-risk (HR 1.61; 95% CI 1.38-1.88, P-value < 0.001) patients. The HR trend in the subgroups of risk confirms the data from the whole mixed population.

Conclusion: In a real-word setting, TAVI is associated with higher incidence of all-cause death and maintains a survival benefit only in the first month after implantation. These results show that TAVI effectiveness may not reflect the efficacy demonstrated by RCTs and pose a threat to their external validity.

简介:随机对照试验(rct)提供了疗效的证据,而现实世界数据(RWD)在现实世界的实践中证明了有效性。我们对经导管主动脉瓣植入术(TAVI)和外科主动脉瓣置换术(SAVR)的倾向评分匹配研究的重构时间到事件(RTE)数据进行了系统回顾和meta分析,以比较它们的有效性并评估TAVI适应症的普遍性。方法:系统回顾2007年至2023年间的文献,包括比较TAVI或SAVR的倾向评分匹配研究,这些研究报告了至少一年的终点Kaplan-Meier曲线。结果:纳入21项研究(39538名受试者)。TAVI显示出更高的全因死亡率(危险比[HR] 1.41;95%置信区间[CI] 1.34-1.47, p值< 0.001),异质性显著。人力资源的长期趋势分析表明,TAVI的优势仅限于第一个月,之后会出现急剧逆转,此时SAVR的优势明显增强。低危TAVI患者的全因死亡率明显更高(HR 1.35;95% CI 1.08-1.69, p值< 0.001)和中间组(HR 1.73;95% CI 1.35-2.22, p值< 0.001)和高危(HR 1.61;95% CI 1.38 ~ 1.88, p值< 0.001)。风险亚组的人力资源趋势证实了整个混合人群的数据。结论:在现实环境中,TAVI与较高的全因死亡发生率相关,并且仅在植入后的第一个月维持生存优势。这些结果表明,TAVI的有效性可能不能反映rct所显示的有效性,并对rct的外部效度构成威胁。
{"title":"Five-Year Mortality of Surgical and Transcatheter Aortic Valve Replacement in the Real-World Scenario: A Systematic Review and Meta-Analysis of Propensity Score Matching Studies.","authors":"Mateo Marin-Cuartas, Bianca Dalbesio, Francesco Pollari, Matteo Scarpanti, Amedeo Anselmi, Manuela de la Cuesta, Miguel Sousa Uva, Jean-Philippe Verhoye, Francesco Musumeci, Fabio Barili, Alessandro Parolari","doi":"10.21470/1678-9741-2024-0048","DOIUrl":"10.21470/1678-9741-2024-0048","url":null,"abstract":"<p><strong>Introduction: </strong>Randomized controlled trials (RCTs) provide evidence of efficacy, while real-world data (RWD) demonstrate effectiveness in real-world practice. We designed a systematic review and meta-analysis of reconstructed time-to-event (RTE) data from propensity score matching studies comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) to compare their effectiveness and evaluate the generalizability of TAVI indications.</p><p><strong>Methods: </strong>Systematic review of literature between 2007 and 2023 including propensity score matching studies comparing TAVI or SAVR that reported at least one-year Kaplan-Meier curves of endpoints.</p><p><strong>Results: </strong>Twenty-one studies were included (39538 participants). TAVI shows a higher all-cause mortality (hazard ratio [HR] 1.41; 95% confidence interval [CI] 1.34-1.47, P-value < 0.001), with a significant heterogeneity. The analysis of HR trend over time shows that TAVI superiority is limited to the first month with a steep reversal afterwards, when SAVR becomes clearly superior. All-cause mortality is significantly higher in TAVI in low-risk (HR 1.35; 95% CI 1.08-1.69, P-value < 0.001) as well as in intermediate (HR 1.73; 95% CI 1.35-2.22, P-value < 0.001) and high-risk (HR 1.61; 95% CI 1.38-1.88, P-value < 0.001) patients. The HR trend in the subgroups of risk confirms the data from the whole mixed population.</p><p><strong>Conclusion: </strong>In a real-word setting, TAVI is associated with higher incidence of all-cause death and maintains a survival benefit only in the first month after implantation. These results show that TAVI effectiveness may not reflect the efficacy demonstrated by RCTs and pose a threat to their external validity.</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 4","pages":"e20240048"},"PeriodicalIF":1.2,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144059530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Is in a Name? 名字的含义是什么?
Pub Date : 2025-04-23 DOI: 10.21470/1678-9741-2024-0221
Rodrigo Cardoso Cavalcante, Laura Mercer-Rosa, Stephanie M Fuller
{"title":"What Is in a Name?","authors":"Rodrigo Cardoso Cavalcante, Laura Mercer-Rosa, Stephanie M Fuller","doi":"10.21470/1678-9741-2024-0221","DOIUrl":"https://doi.org/10.21470/1678-9741-2024-0221","url":null,"abstract":"","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 4","pages":"e20240221"},"PeriodicalIF":0.0,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143993658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviving Duran's Approach to Pericardial Valve Reconstruction in the Pulmonary Position Within the Right Ventricle-to-Pulmonary Artery Conduit: A Compelling Case Report. 恢复Duran入路在右心室至肺动脉导管内肺动脉位置进行心包瓣膜重建:一个令人信服的病例报告。
IF 1.2 Pub Date : 2025-04-23 DOI: 10.21470/1678-9741-2024-0123
Anupam Das, Alok Kumar Sharma, Anirudh Mathur

Various techniques of conduit repair have been employed during valve reconstruction. While Ozaki conduits have streamlined the procedure, their limited availability poses concerns. This case report presents 14-year-old patient with pulmonary atresia and an anomalous left anterior descending artery arising from the right sinus. A right ventricle-to-pulmonary artery conduit was created using Dacron® graft and a trileaflet valve employing Duran's technique of pericardial valve reconstruction, elucidating surgical methodology. In developing countries, the implementation of Duran's technique presents noteworthy advantage allowing for utilization of autologous tissue, addressing challenges associated with PTFE conduits. Unlike PTFE conduits, the results of Duran's technique at the pulmonary position needs to be followed up in a large number of cases.

在瓣膜重建过程中,各种管道修复技术被采用。虽然尾崎管道简化了流程,但其有限的可用性令人担忧。这个病例报告了一个14岁的肺闭锁和一个异常的左前降支起源于右窦。采用Duran的心包瓣膜重建技术,采用涤纶®移植物和三叶瓣膜建立了右心室至肺动脉导管,阐明了手术方法。在发展中国家,Duran的技术的实施呈现出显著的优势,允许利用自体组织,解决与聚四氟乙烯管道相关的挑战。与聚四氟乙烯导管不同,在大量病例中,Duran技术在肺位的结果需要随访。
{"title":"Reviving Duran's Approach to Pericardial Valve Reconstruction in the Pulmonary Position Within the Right Ventricle-to-Pulmonary Artery Conduit: A Compelling Case Report.","authors":"Anupam Das, Alok Kumar Sharma, Anirudh Mathur","doi":"10.21470/1678-9741-2024-0123","DOIUrl":"10.21470/1678-9741-2024-0123","url":null,"abstract":"<p><p>Various techniques of conduit repair have been employed during valve reconstruction. While Ozaki conduits have streamlined the procedure, their limited availability poses concerns. This case report presents 14-year-old patient with pulmonary atresia and an anomalous left anterior descending artery arising from the right sinus. A right ventricle-to-pulmonary artery conduit was created using Dacron® graft and a trileaflet valve employing Duran's technique of pericardial valve reconstruction, elucidating surgical methodology. In developing countries, the implementation of Duran's technique presents noteworthy advantage allowing for utilization of autologous tissue, addressing challenges associated with PTFE conduits. Unlike PTFE conduits, the results of Duran's technique at the pulmonary position needs to be followed up in a large number of cases.</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 4","pages":"e20240123"},"PeriodicalIF":1.2,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144027744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ERRATUM. 勘误表。
Pub Date : 2025-04-04 DOI: 10.21470/1678-9741-2024-0111e
{"title":"ERRATUM.","authors":"","doi":"10.21470/1678-9741-2024-0111e","DOIUrl":"10.21470/1678-9741-2024-0111e","url":null,"abstract":"","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 2","pages":"e20240111e"},"PeriodicalIF":0.0,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143784644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter for Hemodialysis in Persistent Left Superior Vena Cava in a Patient with Aortic Valve Endocarditis. 主动脉瓣心内膜炎患者持续性左上腔静脉血液透析导管的应用。
IF 1.2 Pub Date : 2025-03-28 DOI: 10.21470/1678-9741-2023-0266
Dejan Marković, Sonja Grković, Vladimir Tutuš, Emilija Nestorović, Duško Terzić, Radmila Karan, Milica Karadžić Kočica, Svetozar Putnik

Persistent left superior vena cava (PLSVC) is a common congenital venous anomaly, usually associated with other congenital heart diseases (12%). Its incidence in the general population is 0.5%. In cardiac surgery patients, it is suspected when using the left subclavian vein or left internal jugular vein for central venous catheter or hemodialysis catheter placement. Transthoracic ultrasound exam is useful in confirming the position of catheters in the venous system by injecting a 5% glucose solution that can be visualized in the right atrium after administration through the catheter. Hemodialysis catheters can be inserted in the PLSVC with good catheter function and no major risk in increase of complications.

持续性左上腔静脉(PLSVC)是一种常见的先天性静脉异常,通常与其他先天性心脏病相关(12%)。其在一般人群中的发病率为0.5%。在心脏外科患者中,怀疑使用左锁骨下静脉或左颈内静脉放置中心静脉导管或血液透析导管。经胸超声检查可以通过注射5%葡萄糖溶液来确认导管在静脉系统中的位置,通过导管给药后可以看到右心房。可在PLSVC内置入血液透析导管,导管功能良好,无增加并发症的主要风险。
{"title":"Catheter for Hemodialysis in Persistent Left Superior Vena Cava in a Patient with Aortic Valve Endocarditis.","authors":"Dejan Marković, Sonja Grković, Vladimir Tutuš, Emilija Nestorović, Duško Terzić, Radmila Karan, Milica Karadžić Kočica, Svetozar Putnik","doi":"10.21470/1678-9741-2023-0266","DOIUrl":"10.21470/1678-9741-2023-0266","url":null,"abstract":"<p><p>Persistent left superior vena cava (PLSVC) is a common congenital venous anomaly, usually associated with other congenital heart diseases (12%). Its incidence in the general population is 0.5%. In cardiac surgery patients, it is suspected when using the left subclavian vein or left internal jugular vein for central venous catheter or hemodialysis catheter placement. Transthoracic ultrasound exam is useful in confirming the position of catheters in the venous system by injecting a 5% glucose solution that can be visualized in the right atrium after administration through the catheter. Hemodialysis catheters can be inserted in the PLSVC with good catheter function and no major risk in increase of complications.</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 3","pages":"e20230266"},"PeriodicalIF":1.2,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11952074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Transcutaneous Non-Invasive Blood Gas Analysis for Monitoring Gas Exchange in Pediatric Cardiac Surgical Patients Post Extubation. 经皮无创血气分析监测小儿心脏手术患者拔管后气体交换的评价。
IF 1.2 Pub Date : 2025-03-28 DOI: 10.21470/1678-9741-2024-0010
Gaurav Pandey, Salman Pervaiz Butt, Arshad Ghori, Naveen G Singh

Introduction: Pediatric cardiac surgery patients need close post-extubation monitoring for ventilation. Non-invasive transcutaneous partial pressure of oxygen (TcPO2) and transcutaneous partial pressure of carbon dioxide (TcPCO2) offer continuous insights and in improving care.

Objective: To investigate the correlation of transcutaneous blood gases (TcPO2, TcPCO2) with arterial blood gases i.e. arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2).

Methods: We conducted a study on 30 pediatric post-cardiac surgery patients (four months to three years old) who were extubated and exhibited stable hemodynamics (inotropic score ≤ 5), normal sinus rhythm, and no respiratory or heart failure signs. Continuous transcutaneous and intermittent arterial blood gas monitoring started one hour after extubation, with recordings every 30 minutes for four hours. A single observer conducted probe calibration and data recording to minimize variability, while analysis of 240 paired samples included correlation coefficient, linear regression, Bland-Altman analysis, and Mountain plot.

Results: The r-value between PaCO2 and TcPCO2 was 0.95, r2-value of 0.9060 (P<0.001). Bland-Altman showed a bias of 2.579, and 95% limits of agreement were -6.4 to 1.3. The r-value between PaO2 and TcPO2 was 0.8942, r2-value of 0.7996 (P<0.001); bias of 20.171 and 95% limit of agreement of -0.5 to 40.9. The Mountain plot revealed a median of 2.57 for PaCO2 vs. TcPCO2 and 20.17 for PaO2 vs. TcPO2.

Conclusion: Transcutaneous carbon dioxide values are interchangeable with arterial PaCO2 in our population study, acting as a surrogate in postoperative pediatric cardiac surgery. Confirmation with arterial blood gases is needed if discrepancies occur.

儿科心脏手术患者需要拔管后密切监测通气。无创经皮氧分压(TcPO2)和经皮二氧化碳分压(TcPCO2)提供持续的见解和改善护理。目的:探讨经皮血气(TcPO2、TcPCO2)与动脉血气即动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)的相关性。方法:我们对30例儿童心脏手术后患者(4个月至3岁)进行了研究,这些患者拔管,血流动力学稳定(肌力评分≤5),窦性心律正常,无呼吸或心力衰竭体征。拔管后1小时开始连续经皮间断动脉血气监测,每30分钟记录一次,持续4小时。单个观测者进行探针校准和数据记录,以尽量减少变异,而240个成对样本的分析包括相关系数、线性回归、Bland-Altman分析和Mountain图。结果:PaCO2与TcPCO2的r值为0.95,r2值为0.9060。结论:在本人群研究中,经皮二氧化碳值与动脉PaCO2值可互换,可作为小儿心脏手术后的替代指标。如果出现差异,需要用动脉血气进行确认。
{"title":"Evaluation of Transcutaneous Non-Invasive Blood Gas Analysis for Monitoring Gas Exchange in Pediatric Cardiac Surgical Patients Post Extubation.","authors":"Gaurav Pandey, Salman Pervaiz Butt, Arshad Ghori, Naveen G Singh","doi":"10.21470/1678-9741-2024-0010","DOIUrl":"10.21470/1678-9741-2024-0010","url":null,"abstract":"<p><strong>Introduction: </strong>Pediatric cardiac surgery patients need close post-extubation monitoring for ventilation. Non-invasive transcutaneous partial pressure of oxygen (TcPO2) and transcutaneous partial pressure of carbon dioxide (TcPCO2) offer continuous insights and in improving care.</p><p><strong>Objective: </strong>To investigate the correlation of transcutaneous blood gases (TcPO2, TcPCO2) with arterial blood gases i.e. arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2).</p><p><strong>Methods: </strong>We conducted a study on 30 pediatric post-cardiac surgery patients (four months to three years old) who were extubated and exhibited stable hemodynamics (inotropic score ≤ 5), normal sinus rhythm, and no respiratory or heart failure signs. Continuous transcutaneous and intermittent arterial blood gas monitoring started one hour after extubation, with recordings every 30 minutes for four hours. A single observer conducted probe calibration and data recording to minimize variability, while analysis of 240 paired samples included correlation coefficient, linear regression, Bland-Altman analysis, and Mountain plot.</p><p><strong>Results: </strong>The r-value between PaCO2 and TcPCO2 was 0.95, r2-value of 0.9060 (P<0.001). Bland-Altman showed a bias of 2.579, and 95% limits of agreement were -6.4 to 1.3. The r-value between PaO2 and TcPO2 was 0.8942, r2-value of 0.7996 (P<0.001); bias of 20.171 and 95% limit of agreement of -0.5 to 40.9. The Mountain plot revealed a median of 2.57 for PaCO2 vs. TcPCO2 and 20.17 for PaO2 vs. TcPO2.</p><p><strong>Conclusion: </strong>Transcutaneous carbon dioxide values are interchangeable with arterial PaCO2 in our population study, acting as a surrogate in postoperative pediatric cardiac surgery. Confirmation with arterial blood gases is needed if discrepancies occur.</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 3","pages":"e20240010"},"PeriodicalIF":1.2,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11952150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives of Pediatric Cardiology on the Creation of Pediatric Congenital Heart Surgery Subspecialty in Brazil. 巴西儿科先天性心脏外科亚专科创建的儿科心脏病学观点。
Pub Date : 2025-03-28 DOI: 10.21470/1678-9741-2024-0200
Rachel Vilela de Abreu Haickel Nina, Tainá Belisa Ferreira Rosa, Barbara Neiva Tanaka
{"title":"Perspectives of Pediatric Cardiology on the Creation of Pediatric Congenital Heart Surgery Subspecialty in Brazil.","authors":"Rachel Vilela de Abreu Haickel Nina, Tainá Belisa Ferreira Rosa, Barbara Neiva Tanaka","doi":"10.21470/1678-9741-2024-0200","DOIUrl":"10.21470/1678-9741-2024-0200","url":null,"abstract":"","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 3","pages":"e20240200"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11952209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Study on the Outcomes of Right Ventricular Outflow Tract Stenting vs. Modified Blalock-Taussig Shunt in Patients with Tetralogy of Fallot: A Prospective Randomized Trial. 法洛四联症患者右心室流出道支架置入与改良Blalock-Taussig分流术疗效的比较研究:一项前瞻性随机试验。
IF 1.2 Pub Date : 2025-03-27 DOI: 10.21470/1678-9741-2023-0478
Aleksey V Voitov, Meline G Morsina, Serezha N Manukian, Ilya A Soynov, Nataliya R Nichay, Yury Yu Kulyabin, Aleksey N Arkhipov, Manolis G Pursanov, Artem V Gorbatykh, Alexander V Bogachev-Prokophiev

Objective: To evaluate pulmonary vascular development and outcomes of complete correction following palliative treatment in infants with critical tetralogy of Fallot.

Methods: This prospective, randomized, two-center study included infants with tetralogy of Fallot who underwent surgery between June 2018 and 2022. The patients were divided into two groups - those who underwent stenting of the right ventricular outflow tract (stent group, n=21) and those who underwent modified Blalock-Taussig shunt placement (shunt group, n=21).

Results: In the stent group, a significantly greater increase in Nakata index was observed, with mean values rising from 104.2 to 208.6 mm2/m2, compared to an increase from 107.3 to 169.4 mm2/m2 in the shunt group (P<0.01). According to the mixed model analysis, the rate of growth of the right pulmonary artery in the stent group was 2.05*10-2 z score/day, which was 3.01 times greater than that in the shunt group (P<0.01). The rate of growth of the left pulmonary artery in the stent group was 2.3*10-2 z score/day, which was 1.47 times greater than that in the shunt group (P<0.01). In one patient (4.8%), after 76 days following the stenting of the RVOT, a severe infectious process with sepsis occurred, leading to a fatal outcome. Complete correction in the stent group involved transannular patch repair of the right ventricular outflow tract to the pulmonary artery in 12 patients (60%), while the same procedure was performed in 15 patients (71.4%) in the shunt group (P=0.52).

Conclusion: Stenting of the right ventricular outflow tract provides hemodynamic stabilization and symmetric growth of the pulmonary vascular bed compared to the formation of a modified Blalock-Taussig shunt.

目的:评价危重法洛四联症患儿姑息治疗后肺血管发育及完全矫正的效果。方法:这项前瞻性、随机、双中心研究纳入了2018年6月至2022年接受手术的法洛四联症婴儿。患者被分为两组:右心室流出道支架置入组(支架组,n=21)和改良Blalock-Taussig分流器置入组(分流器组,n=21)。结果:在支架组中,观察到Nakata指数的显著增加,平均值从104.2上升到208.6 mm2/m2,而分流器组从107.3上升到169.4 mm2/m2 (p结论:与改良blallock - taussig分流器的形成相比,右心室流出道支架的植入提供了血流动力学稳定和肺血管床的对称生长。
{"title":"Comparative Study on the Outcomes of Right Ventricular Outflow Tract Stenting vs. Modified Blalock-Taussig Shunt in Patients with Tetralogy of Fallot: A Prospective Randomized Trial.","authors":"Aleksey V Voitov, Meline G Morsina, Serezha N Manukian, Ilya A Soynov, Nataliya R Nichay, Yury Yu Kulyabin, Aleksey N Arkhipov, Manolis G Pursanov, Artem V Gorbatykh, Alexander V Bogachev-Prokophiev","doi":"10.21470/1678-9741-2023-0478","DOIUrl":"10.21470/1678-9741-2023-0478","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate pulmonary vascular development and outcomes of complete correction following palliative treatment in infants with critical tetralogy of Fallot.</p><p><strong>Methods: </strong>This prospective, randomized, two-center study included infants with tetralogy of Fallot who underwent surgery between June 2018 and 2022. The patients were divided into two groups - those who underwent stenting of the right ventricular outflow tract (stent group, n=21) and those who underwent modified Blalock-Taussig shunt placement (shunt group, n=21).</p><p><strong>Results: </strong>In the stent group, a significantly greater increase in Nakata index was observed, with mean values rising from 104.2 to 208.6 mm2/m2, compared to an increase from 107.3 to 169.4 mm2/m2 in the shunt group (P<0.01). According to the mixed model analysis, the rate of growth of the right pulmonary artery in the stent group was 2.05*10-2 z score/day, which was 3.01 times greater than that in the shunt group (P<0.01). The rate of growth of the left pulmonary artery in the stent group was 2.3*10-2 z score/day, which was 1.47 times greater than that in the shunt group (P<0.01). In one patient (4.8%), after 76 days following the stenting of the RVOT, a severe infectious process with sepsis occurred, leading to a fatal outcome. Complete correction in the stent group involved transannular patch repair of the right ventricular outflow tract to the pulmonary artery in 12 patients (60%), while the same procedure was performed in 15 patients (71.4%) in the shunt group (P=0.52).</p><p><strong>Conclusion: </strong>Stenting of the right ventricular outflow tract provides hemodynamic stabilization and symmetric growth of the pulmonary vascular bed compared to the formation of a modified Blalock-Taussig shunt.</p>","PeriodicalId":72457,"journal":{"name":"Brazilian journal of cardiovascular surgery","volume":"40 2","pages":"e20230478"},"PeriodicalIF":1.2,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11951935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brazilian journal of cardiovascular surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1